EMEA-001883-PIP03-17

Key facts

Active substance
pegvorhyaluronidase alpha
Therapeutic area
Oncology
Decision number
P/0320/2019
PIP number
EMEA-001883-PIP03-17
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of all conditions contained in the category of malignant neoplasms (except haematopoietic and lymphoid tissue)
Route(s) of administration
Intravenous use
Contact for public enquiries
Halozyme Inc.

Tel. +1 8448554256
E-mail: medinfo@halozyme.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating